Journal of Infectious Disease Pharmacotherapy最新文献

筛选
英文 中文
West Nile Virus:: Here to Stay 西尼罗河病毒:留在这里
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_02
Deb Schering
{"title":"West Nile Virus:: Here to Stay","authors":"Deb Schering","doi":"10.1300/J100V06N04_02","DOIUrl":"https://doi.org/10.1300/J100V06N04_02","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134228155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetic Profiles of Intravenous Ciprofloxacin 600 Milligram 静脉注射环丙沙星600毫克的药动学特征
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_03
H. Mikamo
{"title":"Pharmacokinetic Profiles of Intravenous Ciprofloxacin 600 Milligram","authors":"H. Mikamo","doi":"10.1300/J100V06N04_03","DOIUrl":"https://doi.org/10.1300/J100V06N04_03","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"94 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131568897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Community-acquired pneumonia: Objective criteria to predict severe disease 社区获得性肺炎:预测重症的客观标准
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_04
C. Frei, D. Burgess
{"title":"Community-acquired pneumonia: Objective criteria to predict severe disease","authors":"C. Frei, D. Burgess","doi":"10.1300/J100V06N04_04","DOIUrl":"https://doi.org/10.1300/J100V06N04_04","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115292192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Development and Optimization of a Reversed Phase High Performance Liquid Chromatographic Method for the Determination of Levofloxacin in Growth Media, Human BAL Fluid, Alveolar Macrophages and Plasma 反相高效液相色谱法测定生长培养基、人BAL液、肺泡巨噬细胞和血浆中左氧氟沙星含量的建立与优化
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_05
Cuilian Zhang
{"title":"Development and Optimization of a Reversed Phase High Performance Liquid Chromatographic Method for the Determination of Levofloxacin in Growth Media, Human BAL Fluid, Alveolar Macrophages and Plasma","authors":"Cuilian Zhang","doi":"10.1300/J100V06N04_05","DOIUrl":"https://doi.org/10.1300/J100V06N04_05","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126524603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Differential Effects of Amphotericin B and Fluconazole on Neutrophil CD11b Expression 两性霉素B和氟康唑对中性粒细胞CD11b表达的差异影响
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_06
D. Healy
{"title":"Differential Effects of Amphotericin B and Fluconazole on Neutrophil CD11b Expression","authors":"D. Healy","doi":"10.1300/J100V06N04_06","DOIUrl":"https://doi.org/10.1300/J100V06N04_06","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126066070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Dietary Supplements with Claims of Antimicrobial Activity 具有抗菌活性的膳食补充剂的评价
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-01-27 DOI: 10.1300/J100V06N03_01
T. B. Klepser
{"title":"Evaluation of Dietary Supplements with Claims of Antimicrobial Activity","authors":"T. B. Klepser","doi":"10.1300/J100V06N03_01","DOIUrl":"https://doi.org/10.1300/J100V06N03_01","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114879720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Role of a Clinical Pharmacist on Drotrecogin Alfa (activated) Outcomes in a Large Community Teaching Hospital 临床药师对大型社区教学医院羟曲霉素(激活)疗效的影响
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-01-27 DOI: 10.1300/J100V06N03_05
S. Kotapati
{"title":"Role of a Clinical Pharmacist on Drotrecogin Alfa (activated) Outcomes in a Large Community Teaching Hospital","authors":"S. Kotapati","doi":"10.1300/J100V06N03_05","DOIUrl":"https://doi.org/10.1300/J100V06N03_05","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"189 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124320972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pharmacoeconomic Aspects of Antibacterial Therapy with Azithromycin of Community-Acquired Pneumonia in Servicemen 阿奇霉素抗菌治疗军人社区获得性肺炎的药物经济学研究
Journal of Infectious Disease Pharmacotherapy Pub Date : 2004-01-27 DOI: 10.1300/J100V06N03_02
Olexander Dzyublyk
{"title":"Pharmacoeconomic Aspects of Antibacterial Therapy with Azithromycin of Community-Acquired Pneumonia in Servicemen","authors":"Olexander Dzyublyk","doi":"10.1300/J100V06N03_02","DOIUrl":"https://doi.org/10.1300/J100V06N03_02","url":null,"abstract":"Study population The study population comprised male military servicemen between the ages of 18 and 21 years, with clinical symptoms and radiological evidence of pneumonia. The patients were classified as low risk in terms of short-term mortality and had not been given antibiotic treatment for 48 hours before treatment was started, unless it had resulted in no clinical improvement. Patients were excluded if they had a history of allergy to beta-lactams or macrolides, severe pneumonia, marked renal or hepatic impairment, or gastrointestinal disorders which could affect absorption. They were also excluded if they had received more than one daily dose of any antimicrobial drug prior to study enrolment.","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115211342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriate Empiric Use of Antibiotics in Gram-Positive Infections:: Clinical Considerations 在革兰氏阳性感染中适当使用经验性抗生素:临床考虑
Journal of Infectious Disease Pharmacotherapy Pub Date : 2003-09-01 DOI: 10.1300/J100V04N04_02
J. Peterson
{"title":"Appropriate Empiric Use of Antibiotics in Gram-Positive Infections:: Clinical Considerations","authors":"J. Peterson","doi":"10.1300/J100V04N04_02","DOIUrl":"https://doi.org/10.1300/J100V04N04_02","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126863619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Considerations Regarding the Administration of Beta-Lactam Antibiotics by Continuous Infusion 持续输注β -内酰胺类抗生素的临床考虑
Journal of Infectious Disease Pharmacotherapy Pub Date : 2003-09-01 DOI: 10.1300/J100V04N04_01
E. Grant
{"title":"Clinical Considerations Regarding the Administration of Beta-Lactam Antibiotics by Continuous Infusion","authors":"E. Grant","doi":"10.1300/J100V04N04_01","DOIUrl":"https://doi.org/10.1300/J100V04N04_01","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124029478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书